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Objectives. The purpose of this study was to describe the results 
of transluminal extraction coronary atherectomy in native coro- 
nary arteries. 
Background. Transluminai extraction coronary atherectomy 
was approved by the Food and Drug Administration for use in 
native coronary arteries and vein grafts. 
Methods. Between December 1988 and July 1992, transluminal 
extraction coronary atherectomy was performed in 181 native 
coronary arteries in 175 patients. A detailed angiographic and 
clinical assessment was performed. 
Results. Quantitative angiography (mean -4- SD) revealed an 
increase in minimal lumen diameter f om 1.0 -+ 0.6 mm before to 
1.3 -+ 0.7 mm after atherectomy, to 2.1 -+ 0.8 mm after final 
treatment (p < 0.001), corresponding to a diameter stenosis of 
70 -+ 16%, 61 --4- 21% and 36 + 21%, respectively (p< 0.001). Final 
procedural success (final diameter stenosis <50%, no major 
complications) was achieved in 84%. Adjunctive angioplasty was 
used after atherectomy in 152 lesions (84%) to further enlarge 
lumen dimensions (130 lesions, 72%), salvage technical failures 
(2 lesions, 1%) and reverse atherectomy-induced abrupt closures 
(20 lesions, 11%). Clinical complications included death (2.3%), 
Q wave myocardial infarction (3.4%) and emergency bypass 
surgery (2.8%). The strongest independent correlate of major 
clinical complications was development ofabrupt closure imme- 
diately after atherectomy (p = 0.01). Clinical follow-up of 92% of 
eligible patients revealed clinical restenosis (repeat intervention, 
late bypass urgery, myocardial infarction or death) in 28.5%. 
Angiographic follow-up of 83% of eligible lesions revealed a 
restenosis rate (diameter stenosis >50%) of 61%. 
Conclusions. Transluminal extraction coronary atherectomy is 
limited by a modest degree of lumen enlargement, frequent need 
for adjunctive angioplasty and a high restenosis rate. For complex 
lesions in native coronary arteries, transluminal extraction coro- 
nary atherectomy appears to offer no advantage over conventional 
balloon angioplasty. 
(J Am Coll Cardiol 1995;25:848-54) 
In addition to conventional balloon angioplasty, several other 
percutaneous laser and atherectomy devices have been used in 
patients with coronary artery disease. Transluminal extraction 
coronary atherectomy is a relatively new technique that was 
recently approved by the Food and Drug Administration for 
use in human coronary arteries and saphenous vein bypass 
grafts (1-3). Transluminal extraction coronary atherectomy 
has the potential ability to cut and aspirate tissue, and it may be 
useful as an alternative revascularization technique. The pur- 
pose of this study was to evaluate the clinical and angiographic 
results of transluminal extraction coronary atherectomy in
complex lesions in native coronary arteries. 
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Methods  
Study patients. Between December 1988 and July 1992, 
transluminal extraction coronary atherectomy was performed 
in 339 lesions in 321 patients. The immediate angiographic 
results and follow-up of 158 saphenous vein graft lesions (146 
patients) were previously reported in detail (3). The present 
study included 181 native coronary artery lesions in 175 
patients (mean [+SD] age 61 _+ 11 years; 122 men, 53 women). 
Aortoostial, ong and thrombus-containing lesions were specif- 
ically targeted for atherectomy, but complex lesions (defined as 
American College of Cardiology/American Heart Association 
class B or C) of various types were also considered. However, 
patients with acute myocardial infarction and target vessels 
<2 mm in diameter were excluded from this study. Anginal 
symptoms were classified according to the Canadian Cardio- 
vascular Society Classification and included class 0 or I in 11% 
of patients, class II in 9%, class III in 50% and class IV in 30%. 
Clinical indications for revascularization included stable an- 
gina in 50% of patients, unstable angina in 39% and postin- 
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farction angina after recent (< 1 month) myocardial infarction 
in 11%. Previous percutaneous intervention (balloon angio- 
plasty or another device) had been performed in 44% of 
lesions, and 24% of patients had undergone previous coronary 
bypass urgery. 
Athereetomy procedure. All atherectomy procedures were 
performed according to a protocol approved by the Human 
Investigations Committee of William Beaumont Hospital. All 
patients were pretreated with aspirin at least 24 h before the 
procedure. After vascular sheath insertion, heparin was admin- 
istered to maintain activated clotting time >300 s; on the 
morning after the procedure, heparin was discontinued, and 
sheaths were removed. The details of the atherectomy proce- 
dure have been described elsewhere (3). In general, the device 
selected was equal to 50% to 70% of the reference vessel 
diameter (device/artery atio 0.5-0.7) and was intended to 
partially debulk the target lesion rather than to achieve 
definitive lumen enlargement. Despite complex lesion mor- 
phology, all target lesions were considered suitable for conven- 
tional balloon angioplasty according to the standards of care at 
William Beaumont Hospital. 
Angiographie assessment. Quantitative angiographic anal- 
ysis was performed immediately before and after each inter- 
vention, using the single view that identified the most severe 
stenosis. Minimal lumen diameter and reference artery diam- 
eter were determined using digital calipers on projected im- 
ages of selected optically magnified cine frames referenced to
the known diameter of the angiographic catheter, as previously 
described (4). All views were selected with the target lesion 
and reference guiding catheter in the same plane, maximally 
elongated and centered to reduce vessel foreshortening and 
pincushion distortion. Intracoronary nitroglycerin (0.1 to 
0.2 mg) was routinely administered before and after each 
intervention. This technique has been shown to provide excel- 
lent agreement with other computerized edge detection and 
densitometric techniques over a wide range of arterial dimen- 
sions (5-8). Measurements were obtained immediately before 
and after atherectomy and after balloon angioplasty (by 
R.D.S.). 
The ratio of the diameter of the final device to the diameter 
of the reference vessel (device/artery ratio) was a measure of 
relative device sizing (9). The ratio of the residual lumen 
diameter immediately after atherectomy to the final atherec- 
tomy cutter diameter (the diameter of the cutter [mm] was 
calculated by dividing the French size by 3) is a measure of the 
relative lumen diameter achieved, normalized for the size of 
the cutter, and is a direct measure of the mechanical efficiency 
of lumen enlargement (9). 
For purposes of analysis, lesion characteristics were cate- 
gorized as dichotomous variables (present or absent). Lesions 
were considered eccentric if they occupied the outer quarter of 
the vessel umen, and ulcerated lesions were defined as those 
with definite overhanging edges (lesions with simple contour 
irregularity were not considered ulcerated). Thrombus was 
considered present if there was a definite circumscribed filling 
defect, but intraluminal haziness alone was not considered 
sufficient evidence for thrombus. Lesion angulation was graded 
as none, mild (<45 ° angle), moderate (45 ° to 600 angle) or 
severe (>60 ° angle). Vessel tortuosity proximal to the lesion 
was graded as none, mild (one bend -<90°), moderate (two 90 ° 
bends) or severe (more than two 900 bends). Lesions were also 
classified according to the modified American College of 
Cardiolo~/American Heart Association classification (10). 
Anterograde flow was graded after transluminal extraction 
atherectomy and after subsequent balloon angioplasty using 
standard Thrombolysis n Myocardial Infarction (TIMI) crite- 
ria (11). Dissections were graded on a scale from 0 to 4 (0 = no 
dissection; 1 = mild focal dissection; 2 = moderate dissection 
with <50% diameter stenosis; 3 = severe dissection with 
>50% diameter stenosis; 4 = severe dissection with total 
occlusion), as previously described (3,12,13). 
Follow-up. Follow-up was performed by clinic visit or 
telephone contact with the patient or referring physician. 
Repeat angiography was recommended to all patients at 6 
months, or earlier if necessary for recurrence of symptoms. 
Definitions. As described previously (3,12), procedural suc- 
cess was defined as a final diameter stenosis <50% in the 
absence of a major complication (death, emergency bypass 
surgery or Q wave myocardial infarction). Distal embolization 
was defined as the appearance of new circumscribed filling 
defects or abrupt cutoff of the vessel distal to the target lesion, 
or both. Abrapt closure was defined as poor anterograde flow 
(TIMI flow grade -<1) due to acute occlusion of the target 
lesion. No reflow was defined as TIMI flow grade -<1 that could 
not be explained by severe dissection or abrupt closure of the 
original target lesion. To prevent double counting, if no reflow 
was attributed to distal embolization, then only no reflow was 
entered as an angiographic complication. Angiographic resten- 
osis was defined as a diameter stenosis >50% at follow-up and 
clinical restenosis as revascularization f the target lesion 
(balloon angioplasty or another device or coronary artery 
bypass urgery), myocardial infarction or cardiac death. 
Statistical analysis. Data are reported as mean value _+ 
SD. Comparisons were made using the Student test for 
continuous variables. Chi-square analysis was used to compare 
categoric variables and logistic regression to determine asso- 
ciations between clinical factors and outcome. Univariate 
analysis was performed for 40 demographic, linical and 
angiographic variables, and variables associated with p < 0.10 
were entered into the multivariate analysis to identify indepen- 
dent correlates of outcome. Statistical analyses were per- 
formed with available software (JMP, SAS Institute); p < 0.05 
was considered significant. 
Resul ts  
Baseline angiography. The extent of coronary artery dis- 
ease was limited to one (45%), two (27%) or three vessels 
(28%), and mean left ventricular ejection fraction was 52 _+ 
9%. Target lesions were located in the left main (10%), left 
anterior descending (32%), left circumflex (7%) or right (51%) 
coronary artery. Complex lesion morphology was frequently 
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Table 1. Baseline Morphology of 181 Native Coronary Artery 
Lesions Treated by Transluminal Extraction Coronary Atherectomy 
No. (%) 
Morphology of Lesions 
Chronic total occlusion 7 (4) 
Aorto-ostial/origin 56 (31) 
Bifurcation 15 (8) 
Calcification 55 (31) 
Eccentric lumen 129 (71) 
Ulcerated contour 29 (16) 
Thrombus 8 (5) 
Angulation 
None/mild 151 (83) 
Moderate 28 (16) 
Severe 2 (1) 
Tortuosity 
None/mild 155 (85) 
Moderate 25 (14) 
Severe 1 (0.5) 
Length 
Focal 118 (65) 
Tubular 48 (27) 
Diffuse 15 (8) 
ACC/AHA class* 
A l l  (6) 
BI 36 (20) 
B2 110 (61) 
C 24 (13) 
*As defined in reference 10. ACC/AHA = American College of Cardiology/ 
American Heart Association. 
identified, including type B or C lesion characteristics (94%), 
chronic total occlusion (3%), ostial location (31%), eccentric- 
ity (71%), ulceration (16%), moderate to severe angulation 
(17%) and intraluminal filling defects consistent with throm- 
bus (5%) (Table 1, Fig. 1). 
Immediate results. The atherectomy cutter was success- 
fully advanced through 179 lesions (99%), but failed to cross 2 
(1%) that were treated successfully by balloon angioplasty. The 
final atherectomy cutter size was 5.5F (26%), 6F (21%), 6.5F 
(11%), 7F (26%) or 7.5F (16%). Mean cutter diameter was 
6.4 _+ 0.7F (2.1 -- 0.2 ram), and 1.5 _ 0.6 cutters/lesion were 
used. The device/artery atio was 0.65 _+ 0.1, consistent with 
relative undersizing of the cutters versus the normal reference 
diameter. 
Quantitative angiographic analysis revealed a reference di- 
ameter of 3.4 _+ 0.9 mm and a lesion length of 7.1 _+ 6.4 ram. 
Lumen diameter increased from 1.0 + 0.6 mm before to 1.3 + 
0.7 mm after atherectomy, to 2.1 _+ 0.8 mm after final 
treatment (p< 0.001). These absolute diameters corresponded 
to decreases in diameter stenosis from 70 _ 16% before to 61 
_+ 21% after atherectomy, to 36 _+ 21% after final treatment (p
< 0.001) (Fig. 2). The efficiency of lumen enlargement for 
transluminal extraction coronary atherectomy was 0.70 _+ 0.25, 
indicating that the lumen diameter achieved after atherectomy 
was equal to 70% of the final cutter diameter and that 30% of 
the cutter diameter was lost to elastic recoil, spasm or other 
causes of inadequate lumen enlargement. After atherectomy, a 
Figure 1. Angiograms of right coronary artery before and after 
transluminal extraction coronary atherectomy. Top, Baseline angiog- 
raphy in the left (left) and right (right) anterior oblique projections 
revealed a subtotal eccentric and hazy stenosis in the midvessel, 
suggestive of thrombus. Middle, A 7F atherectomy cutter was ad- 
vanced across the lesion (left), leaving a smooth lumen without 
haziness (right), suggesting complete thrombus removal. Bottom, 
After adjunctive angioplasty, here was no significant residual stenosis 
in the left (left) or right (right) anterior oblique projections. 
decrease indiameter stenosis ->20% was achieved in 51 lesions 
(28%). In contrast, a decrease in diameter stenosis <20% was 
observed in 130 lesions (72%), including minimal or no change 
in stenosis (decrease in diameter stenosis 0% to 19%) in 80 
lesions (44%) or worsening of diameter stenosis in 50 lesions 
(28%). Only 52 lesions (29%) had residual diameter stenosis 
-<50% after atherectomy. However, final procedural success 
(with or without adjunctive balloon angioplasty) was achieved 
in 152 lesions (84%). 
Immediately after atherectomy, lumen enlargement was 
significantly better for aorto-ostial lesions (p < 0.05) and worse 
for lesions >20 mm long (p < 0.01) and chronic total 
occlusions (p < 0.05). However, after adjunctive balloon 
angioplasty, lumen enlargement was similar for all morpho- 
logic subsets. 
Adjunctive balloon angioplasty. Transluminal extraction 
coronary atherectomy was used as the only intervention i 29 
lesions (16%). Adjunctive balloon angioplasty was used after 
atherectomy in 152 lesions (84%) to further enlarge lumen 
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Figure 2. Absolute lumen diameter (top) and percent diameter steno- 
sis (bottom) after transluminal extraction coronary atherectomy in 181 
lesions in native coronary arteries. Data are expressed asa percent of 
all treated lesions. Bold line = reference diameter; thin line = baseline 
dimensions; dotted squares = residual dimensions after transluminal 
extraction coronary atherectomy; circles = final dimensions. 
dimensions (130 lesions, 72%), salvage technical failures 
(2 lesions, 1%) and reverse atherectomy-induced vessel occlu- 
sions (20 lesions, 11%). Laser balloon angioplasty was used 
successfully to manage atherectomy-induced abrupt closure 
after failure of adjunctive balloon angioplasty in one lesion. 
Predilation (and postdilation) were required in two lesions 
(1%) and directional atherectomy in one (0.5%) after subop- 
timal adjunctive balloon angioplasty. For lesions in which 
adjunctive balloon angioplasty was required, an average of 
1.3 _+ 0.5 balloons/lesion were used, with average balloon 
diameter of 3.3 _+ 0.5 mm. 
Lumen morphology after intervention. A smooth lumen 
contour was observed in 72 lesions (40%) after atherectomy 
and in 97 (53%) after final angiography (Fig. 1). Angiographic 
evidence for dissection was detected in 70 lesions (39%), 
including mild or moderate dissection (grade 1 or 2) in 33 
lesions (18%), severe dissection with high grade residual 
stenosis (grade 3) in 17 (10%) and severe dissection with total 
vessel occlusion in 20 (11%). After final angiography, angio- 
Table 2. Assessment of Anterograde Flow in 181 Native Coronary 
Artery. Lesions Treated by Transluminal Extraction Coronary 
Atherectomy With or Without Coronary Balloon Angioplasty 
TIMI Flow Atherectomy After Final 
Grade* Baseline After TEC Angiography 
0 4 (2.2) 15 (8.3) 3 (1.6) 
1 3 (1.6) 5 (2.7) 3 (1.6) 
2 18 (9.9) 11 (6.1) 1 (0.5) 
3 156 (86.2) 150 (82.9) 174 (96.2) 
*As defined in reference 11. Data presented are number (%) of lesions. 
TEC = transluminal extraction coronary; TIMI = Thrombolysis in Myocardial 
Infarction. 
graphic evidence for dissection was detected in 75 lesions 
(41%), including mild or moderate dissection in 63 (35%), 
severe dissection with high grade residual stenosis in 7 (4%) 
and severe dissection with total occlusion in 5 (2.7%). New 
filling defects consistent with thrombus or dissection, or both, 
were observed in three lesions (1.7%) after atherectomy, but 
none remained after adjunctive balloon angioplasty. 
Angiographic complications. Significant angiographic com- 
plications were observed in 36 lesions (20%), including 
atherectomy-induced complications in 34 (18.8%) and angio- 
plasty-induced complications in 2 (1.0%) (Table 3). Severe 
dissection leading to abrupt closure occurred in 21 lesions 
(11.5%), including those due to atherectomy in 20 (11.0%) and 
balloon angioplasty in 1 (0.5%). Abrupt closure persisted in 5 
lesions (2.7%) despite prolonged balloon inflations (n = 21), 
laser balloon angioplasty (n = 1) and salvage directional 
atherectomy (n = 1). Coronary artery perforation was observed 
in four lesions (2.2%) immediately after atherectomy, leading 
to contained rupture without amponade in two patients and 
free perforation with tamponade in another two, both of whom 
underwent balloon angioplasty and pericardiocentesis without 
surgical intervention. Air embolization occurred after atherec- 
tomy in one lesion (0.5%) and atheromatous embolization 
after balloon angioplasty in another (0.5%), both without 
clinical sequelae. Side-branch occlusion occurred in five lesions 
after atherectomy (2.7%), none of which required retrieval. 
Atherectomy-guiding catheter dissection occurred in four lesions 
(2.2%). The final incidence of angiographic complications was 
Table 3. Angiographic Complications i  181 Native Coronary Artery 
Lesions Treated by Transluminal Extraction Coronary Atherectomy 
With or Without Balloon Angioplasty 
Persisting 
Due to TEC After 
Complication Atherectomy Due to PTCA PTCA 
Side-branch occlusion 5 (2.7) 0 5 (2.7) 
Distal embolization 1 (0.5)* 1 (0.5) 0 
Abrupt closure 20 (11.0) 1 (0.5) 5 (2.7) 
Guide dissection 4 (2.2) 0 0 
Perforation 4 (2.2) 0 0 
*Air embolism. Data presented are number (%) of lesions. PTCA = balloon 
angioplasty; TEC = transluminal extraction coronary. 
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Table 4. Clinical Complications After Transluminal Extraction 
Coronary Atherectomy With or Without Adjunctive Balloon 
Angioplasty in 175 Patients 
Complication No. (%) of Patients 
Death 4 (2.3) 
Emergency bypass urgery 5 (2.8) 
Q wave myocardial infarction 6 (3.4) 
Percutaneous cardiopulmonary b pass 3 (1.7) 
lntraaortic balloon pump 8 (4.6) 
Vascular epair 1 (0.6) 
Transfusion 10 (5.7) 
Stroke 1 (0.6) 
Ventricular tachycardia 2 (1.1) 
Temporary pacemaker 2 (I.1) 
Renal failure 1 (0.6) 
Anaphylaxis 1 (0.6) 
5.4%, including persistent side-branch occlusion in five lesions 
(2.7%, all without sequelae) and persistent abrupt closure in 
another five (2.7%, all treated with emergency bypass urgery). 
Clinical complications. Of 175 patients treated with atherec- 
tomy, 4 died in hospital (2.3%), including 2 >80 years who 
died suddenly after apparently successful atherectomy of the 
left anterior descending coronary artery of delayed abrupt 
closure of the target lesion (1 patient with unprotected left 
main coronary artery disease [who was not a candidate for 
bypass urgery] underwent successful atherectomy of the left 
main coronary artery but died suddenly before discharge, 
presumably ofdelayed abrupt closure; and 1 patient developed 
atherectomy-induced abrupt closure of the left anterior de- 
scending coronary artery and died several days later despite 
emergency percutaneous cardiopulmonary b pass upport and 
immediate coronary artery bypass urgery) (Table 4). Emer- 
gency bypass urgery was required in five patients (2.8%) with 
abrupt closure, including the patient who died despite cardio- 
pulmonary bypass upport, as just described. Abrupt closure 
resulted in Q wave myocardial infarction in six patients (3.4%). 
The hierarchic incidence of major complications (death, emer- 
gency bypass surgery or Q wave myocardial infarction) was 
6.4%. 
Percutaneous hemodynamic support was used in 11 patients 
(6.3%), including 8 (4.6%) who required emergency insertion 
of an intraaortic balloon pump, 2 (1.1%) with poor left 
ventricular function who underwent atherectomy with planned 
cardiopulmonary b pass upport and 1 (0.6%) who required 
emergency cardiopulmonary b pass upport, as described ear- 
flier. Significant vascular injury occurred in 11 patients (6.3%), 
:equiring femoral vascular repair in 1 (0.6%) and blood trans- 
fusion in 10 (5.7%). Coronary artery perforation leading to 
cardiac tamponade occurred in two patients (1.1%) and was 
treated by prolonged balloon inflations and pericardiocentesis 
without bypass urgery. Other complications included stroke 
(one patient, 0.6%), transient ventricular tachycardia requiring 
countershock (two patients, 1.1%), transient bradycardia re- 
quiring a temporary transvenous pacemaker (two patients, 
1.1%) and anaphylaxis due to low molecular weight dextran 
(one patient, 0.6%). 
Correlates of severe complications. Univariate analysis was 
unable to identify statistically significant correlates of severe 
angiographic omplications from a variety of demographic, 
clinical and angiographic variables. Using a composite clinical 
end point, defined as in-hospital death, emergency bypass 
surgery or myocardial infarction, independent correlates of an 
adverse clinical outcome included advanced age (p < 0.05), 
treatment of an ulcerated lesion (p < 0.05) and development 
of abrupt closure immediately after atherectomy (p = 0.01). 
Follow-up. Although the original cohort consisted of 175 
patients with 181 lesions, 9 patients with 9 lesions were 
excluded from follow-up because of failure to cross the stenosis 
in 2 patients, emergency bypass urgery in 4 and in-hospital 
death in 4 (of whom 1 had emergency bypass surgery). 
Complete clinical follow-up was available in 153 (92%) of 166 
eligible patients at an mean interval of 6.1 _+ 2.6 months after 
discharge. 
As reported by the patients, anginal symptoms were less- 
ened in 99 (65%), unchanged in 29 (19%) and increased in 25 
(16%) compared with anginal symptoms immediately before 
atherectomy. Anginal symptoms were classified as class 0 in 75 
patients (49%), class I in 12 (8%), class II in 20 (13%), class III 
in 20 (13%) and class IV in 26 (17%). Late clinical outcome 
included recurrent angina treated with medical therapy in 30 
patients (20.2%), repeat percutaneous intervention in the 
original target lesion in 21 (13.5%) and in a new lesion in 4 
(2.2%), coronary bypass urgery in 18 (11.8%), Q wave myo- 
cardial infarction in 2 (1.3%) and late cardiac death in 3 
(1.9%). Clinical restenosis, defined as repeat percutaneous 
intervention in the original target lesion, need for coronary 
bypass urgery, late myocardial infarction or death, occurred in 
44 patients (28.5%). 
Complete angiographic follow-up was available in 143 
(83%) of 172 eligible lesions. Quantitative angiography re- 
vealed a reference diameter of 3.5 + 0.8 mm, a minimal umen 
diameter of 1.5 + 0.9 ram, a lesion length of 7.1 + 4.5 mm and 
a diameter stenosis of 57 _+ 24%. If restenosis defined as a 
diameter stenosis >50%, 87 lesions (61%) had angiographic 
evidence for restenosis, including 17 (11.9%) with total occlu- 
sion of the original target lesion. The restenosis rate for new 
lesions (55%) was lower than that for restenosed lesions (65%, 
p = 0.07) (Fig. 3). 
Discussion 
Several different rotational atherectomy devices are now 
approved for use in human coronary arteries, including direc- 
tional atherectomy, high speed mechanical rotational atherec- 
tomy (Rotablator) and transluminal extraction coronary 
atherectomy. Transluminal extraction coronary atherectomy, 
which relies on cutting and aspiration of tissue, thrombus and 
other debris, is unlike other atherectomy devices that rely on 
tissue cutting, storage and retrieval (directional atherectomy) 
or tissue abrasion and pulverization (Rotablator). 
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Figure 3. Percent diameter stenosis at follow-up, expressed as a 
percent of all lesions (dotted squares) available for angiographic 
follow-up (n = 143 lesions, 83% of lesions eligible for follow-up), p = 
0.07 for new (dashed lines) versus restenosed (solid lines) lesions. 
Quantitative angiographic results. The magnitude of lu- 
men enlargement immediately after transluminal extraction 
coronary atherectomy was disappointing. The average residual 
lumen diameter after atherectomy was only 1.3 _+ 0.7 ram, 
which corresponded to a postatherectomy residual diameter 
stenosis of 61 _+ 21%. These results are similar to those 
reported by Popma et al. (2) and Safian et al. (3). However, the 
high grade residual stenosis was consistent with planned use of 
undersized evices (device/artery atio 0.65 _+ 0.10), lack of 
availability of cutter diameters >2.5 mm and the relatively 
large diameter of the target vessels (reference diameter 3.4 _+ 
0.9 ram). The efficiency of lumen enlargement (0.70 - 0.25) 
suggests that the residual umen diameter and elastic recoil 
after atherectomy were equal to 70% and 30% of the final 
cutter diameter, respectively, which are similar to balloon 
angioplasty. However, both transluminal extraction coronary 
atherectomy and balloon angioplasty are less efficient han the 
Rotablator (91% efficient), excimer laser angioplasty (85% 
efficient), laser balloon angioplasty (80% efficient) and stenting 
(100% efficient) (5,14). 
Transluminal extraction coronary atherectomy and ad- 
junctive angioplasty. The ease of use and flexibility of the 
transluminal extraction catheter are reflected by the finding 
that 99% of lesions were accessible to the device. However, 
residual diameter stenosis <50% immediately after atherec- 
tomy was achieved in only 29% of lesions, also consistent with 
planned use of undersized evices and lack of availability of 
larger cutters. Final procedural success (with or without ad- 
junctive balloon angioplasty) was achieved in 84% of lesions. 
Despite similar efficiency of lumen enlargement for trans- 
luminal extraction coronary atherectomy and balloon angio- 
plasty, adjunctive balloon angioplasty was used in 84% of 
lesions, which is similar to the use of balloon angioplasty in 
86% to 91% of lesions reported by Popma et al. (2) and Safian 
et al. (3). Balloon angioplasty was used to further enlarge 
lumen dimensions (72%), salvage technical failures (1%) and 
reverse atherectomy-induced abrupt closure (11%). The final 
diameter stenosis of 36% in this study is similar to that 
expected after balloon angioplasty alone. Lumen morphology 
was also improved after adjunctive balloon angioplasty because 
the incidence of severe dissection decreased from 21% after 
atherectomy to 6.7% after final angiography. 
Angiographic and clinical complications. Even when the 
high incidence of complex lesions is taken into account, the 
overall incidence of angiographic omplications was high. 
Significant angiographic complications occurred in 36 lesions 
(20%), and all but two complications (1%) were attributed to 
atherectomy. The incidence of abrupt closure (11%) and 
coronary artery perforation (2.2%) was somewhat higher than 
that reported after conventional balloon angioplasty or direc- 
tional or Rotablator atherectomy (13,15-17). However, the 
development of abrupt closure appears to be largely unpre- 
dictable because there were no apparent predictors of abrupt 
closure among 40 demographic, clinical and angiographic 
variables. In keeping with the ability of the atherectomy device 
to aspirate tissue, no reflow was not observed in any patient. 
Fortunately, adjunctive balloon angioplasty was successful 
in 75% of abrupt closures. Accordingly, the incidence of 
serious clinical complications compares favorably with recent 
reports of directional and Rotablator atherectomy (13,18,19). 
However, the incidence of death (2.3%), emergency bypass 
surgery (2.7%) and Q wave myocardial infarction (3.4%) was 
slightly higher than that reported in a recent large series of 
patients undergoing conventional balloon angioplasty for com- 
plex lesions (20). Atherectomy-induced abrupt closure was the 
strongest independent correlate of adverse clinical outcome, 
suggesting that this complication isclinically important even if 
it can be reversed by subsequent balloon angioplasty. 
Late outcome, When the conventional dichotomous defi- 
nition of restenosis i used, the 6-month angiographic resten- 
osis rate after atherectomy is 61%, which is higher than the 
restenosis rates reported after directional and Rotablator 
atherectomy (13,18,19). The restenosis rate for new lesions was 
55%, which was similar to that reported for balloon angioplasty 
in recent randomized trials of balloon angioplasty and direc- 
tional atherectomy (18,19). The clinical restenosis rate (revas- 
cularization of the original target lesion, myocardial infarction 
or death) of 28.5% is similar to that reported for directional 
atherectomy and Rotablator (13,18,19). 
Recommendations for use of transluminal extraction cor- 
onary atherectomy in native vessels. Although this was a 
retrospective observational study, certain recommendations 
can reasonably be made. In the present study, transluminal 
extraction coronary atherectomy (with or without balloon 
angioplasty) did not offer clear advantages over expected 
results for balloon angioplasty of comparable sions, either in 
terms of immediate orlong-term angiographic results or safety. 
Furthermore, transluminal extraction coronary atherectomy is 
significantly limited by the small diameter of available cutters 
and the frequent need for adjunctive balloon angioplasty. 
Because some studies suggest hat transluminal extraction 
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coronary atherectomy has limited ability to remove atheroscle- 
rotic tissue but may be highly efficient for aspiration of 
thrombus (21,22), transluminal extraction coronary atherec- 
tomy might be considered for lesions in native coronary 
arteries or vein grafts that are associated with thrombus. 
However, other adjunctive technologies, uch as balloon an- 
gioplasty, directional therectomy or stenting, may be needed 
for definitive lumen enlargement. 
Limitations of the study. There are several important 
limitations of the present study. First, it was a nonrandomized 
observational study and as such was not designed to determine 
the best reatment for patients with stenoses in native coronary 
arteries. Second, the frequent use of adjunctive balloon angio- 
plasty in this study raises the question as to whether these 
lesions could have been treated by balloon angioplasty alone. 
However, the present study was designed to evaluate the 
results of transluminal extraction coronary atherectomy asa 
debulking device, not to directly compare atherectomy with 
balloon angioplasty or any other interventional strategy. Third, 
significant correlates of severe angiographic complications did 
not include intraluminal thrombus, which seems contrary to 
reported experience with balloon angioplasty. The incidence of 
intraluminal thrombus in this study was only 5%, which may 
partially explain our failure to identify thrombus as a risk factor 
for severe angiographic complications. However, other studies 
of vein grafts have identified thrombus as an important risk 
factor for angiographic and clinical complications (23). Finally, 
the results of the present study should be considered in the 
context of evaluating a first-generation atherectomy cutter. 
Future design modifications, more aggressive atherectomy and 
greater operator experience could have a significant impact on 
the results and complications. 
Conclusions. Transluminal extraction coronary atherec- 
tomy can be applied to complex lesions in native coronary 
arteries but is limited by the small diameter of available cutters 
and by suboptimal angiographic results, frequently requiring 
adjunctive angioplasty. Transluminal extraction coronary 
atherectomy, with or without balloon angioplasty, did not 
appear to have any impact on restenosis. For complex lesions 
in native coronary arteries, transluminal extraction coronary 
atherectomy appears to offer no advantage over conventional 
balloon angioplasty. 
We wish to express our gratitude to Pat McGee and Rita Curtis for technical 
assistance. 
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